PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 8 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

23 May 2026

  1. (diff | hist) m b 05:21 Third-party testing 7,489 ±0 StubSorterBot (talk | contribs) bot: flag bare reference [rollback]
  2. (diff | hist) m 00:19 Deamidation 5,263 ±0 SigFigSindri (talk | contribs) convert the method-comparison paragraph to a table [rollback]

22 May 2026

  1. (diff | hist) 16:43 Sharps disposal 2,040 ±0 ImportPolicyIggy (talk | contribs) copyedit [rollback]
  2. (diff | hist) m 14:33 CagriSema 5,687 ±0 ColdChainCleo (talk | contribs) correct the dose ladder — the maintenance dose is not the maximum dose [rollback]
  3. (diff | hist) 14:15 Talk:Methionine oxidation 748 +147 StabilityStig (talk | contribs) /* Polysorbate peroxides */ reply
  4. (diff | hist) 13:55 Talk:Body composition assessment 748 +100 DEXA_Dilys (talk | contribs) /* Lean mass is not muscle */ reply
  5. (diff | hist) 11:12 Patent expiry and biosimilars 4,553 ±0 AnalyticalAnnie (talk | contribs) consistent en dashes in ranges [rollback]
  6. (diff | hist) 10:40 Talk:Methionine oxidation 537 +149 ScopeSeverin (talk | contribs) /* Polysorbate peroxides */ new section
  7. (diff | hist) 10:20 Talk:Body composition assessment 537 +110 SarcopeniaSefa (talk | contribs) /* Lean mass is not muscle */ new section
  8. (diff | hist) N 09:00 Sharps disposal 2,040 +2,040 RotationRosalind (talk | contribs) start article; worked example to follow
  9. (diff | hist) 08:06 Lot traceability 5,317 ±0 Chromatokid (talk | contribs) state that the sample was not drawn blind, so it represents the vial and not the lot [rollback]
  10. (diff | hist) 07:20 Tianjin Finder Chemical 14,449 ±0 SecondarySrc_Seb (talk | contribs) add the reception tally with its period and count stated [rollback]

21 May 2026

  1. (diff | hist) m 23:55 Temperature excursion 24,964 ±0 ResinRhoswen (talk | contribs) add the data-logger point: an unlogged shipment has no excursion record [rollback]
  2. (diff | hist) 22:25 Insulin syringe 4,944 ±0 ThymosinTamsin (talk | contribs) fix a broken wikilink [rollback]
  3. (diff | hist) 18:46 Melanotan II 4,649 ±0 TirzTaxonomist (talk | contribs) state which receptor subtype the binding data refers to [rollback]
  4. (diff | hist) 15:43 Guangzhou JEEP Biotechnology 15,452 ±0 MergeMorwenna (talk | contribs) attribute the documentation description to the purchaser reports it comes from [rollback]
  5. (diff | hist) 14:35 Talk:Dulaglutide 748 +152 TrialsTabitha (talk | contribs) /* REWIND population */ reply
  6. (diff | hist) 13:50 Talk:Crude peptide 748 +121 CrudePeptidePearl (talk | contribs) /* Identity matters more, not less */ reply
  7. (diff | hist) 13:27 Peptide synthesis 5,649 ±0 DefinedTermDov (talk | contribs) state the residual-moisture target with the method it is measured by [rollback]
  8. (diff | hist) 11:43 Drug master file 4,325 ±0 PreregPriya (talk | contribs) state that a GMP claim is not a fact until assessed [rollback]
  9. (diff | hist) 11:30 Nantong Guangyuan Chemical 15,114 ±0 SecondarySrc_Seb (talk | contribs) move a stray full stop inside the reference [rollback]
  10. (diff | hist) 11:10 Talk:Dulaglutide 537 +242 ForestPlotFinn (talk | contribs) /* REWIND population */ new section
  11. (diff | hist) 10:28 Repackaging 4,759 ±0 GIP_Genoveva (talk | contribs) state that overlay gas is used and name it [rollback]
  12. (diff | hist) 10:15 Talk:Crude peptide 537 +115 MassSpecMarv (talk | contribs) /* Identity matters more, not less */ new section
  13. (diff | hist) 08:36 Talk:Cold chain 1,507 +232 eGFR_Esme (talk | contribs) /* Domestic refrigerator claim: which studies? */ reply
  14. (diff | hist) m 06:54 Medutest 5,018 ±0 ReportReaderRilla (talk | contribs) state the date range the submitted set covers [rollback]
  15. (diff | hist) m 05:54 USP General Chapter 71 4,657 ±0 MassSpecMarv (talk | contribs) rm the vendor name from a methodological sentence [rollback]
  16. (diff | hist) 05:50 Sangon Biotech 14,764 ±0 PurityClaimPia (talk | contribs) add the research-use-only statement to the lead rather than only the footer [rollback]
  17. (diff | hist) m b 04:33 Peptide 6,813 ±0 CategoryBot (talk | contribs) bot: normalise unit spacing [rollback]
  18. (diff | hist) m b 04:02 Liraglutide 5,967 ±0 CiteBot (talk | contribs) bot: expand DOI to full citation [rollback]
  19. (diff | hist) 03:11 Fmoc chemistry 4,618 ±0 TFA_Counterion (talk | contribs) add the figure for the lyophilisation cycle and caption it [rollback]

20 May 2026

  1. (diff | hist) m b 21:41 Vial filling and stoppering 4,833 ±0 ArchiveBot (talk | contribs) bot: normalise unit spacing [rollback]
  2. (diff | hist) m 18:08 Wuhan Wansheng Biotechnology 15,849 ±0 ReportReaderRilla (talk | contribs) add the note that self-published material is usable only for what it states about itself [rollback]
  3. (diff | hist) m 15:41 Good manufacturing practice 5,123 ±0 BatchNumberBede (talk | contribs) correct the agency abbreviation at first use [rollback]
  4. (diff | hist) 14:40 Talk:High-performance liquid chromatography 885 +145 GradientGus (talk | contribs) /* Should sub-2-micron particles be covered? */ reply
  5. (diff | hist) 14:05 Talk:Vial filling and stoppering 748 +85 StopperingSteff (talk | contribs) /* Two-stage stoppering */ reply
  6. (diff | hist) 13:50 Talk:Prior authorisation 748 +80 FormularyFrida (talk | contribs) /* Reauthorisation on response */ reply
  7. (diff | hist) 12:10 GLP-1 receptor 7,570 ±0 GIP_Genoveva (talk | contribs) expand §Structure and ligand engagement [rollback]
  8. (diff | hist) 11:54 Reconstitution of lyophilised peptides 5,761 ±0 TimelineTiernan (talk | contribs) clarify that the figure is per dose, not per vial [rollback]
  9. (diff | hist) 11:05 Talk:High-performance liquid chromatography 674 +122 ColumnOvenCoy (talk | contribs) /* Should sub-2-micron particles be covered? */ new section
  10. (diff | hist) 11:01 Blind sampling 8,193 ±0 MelanocortinMil (talk | contribs) rm the aggregate pass-rate figure; the denominator is not knowable [rollback]
  11. (diff | hist) 10:30 Talk:Vial filling and stoppering 537 +160 LyophilLena (talk | contribs) /* Two-stage stoppering */ new section
  12. (diff | hist) 10:15 Talk:Prior authorisation 537 +105 AppealsArno (talk | contribs) /* Reauthorisation on response */ new section
  13. (diff | hist) 08:30 Talk:Beta cell function 822 +123 PlainNumbersPip (talk | contribs) /* Indices table is hard going */ reply
  14. (diff | hist) 02:16 PolyPeptide Group (Hangzhou) 18,363 ±0 PurityClaimPia (talk | contribs) add the note that self-published material is usable only for what it states about itself [rollback]

19 May 2026

  1. (diff | hist) 17:57 FLOW trial 4,583 ±0 GsCouplingGil (talk | contribs) rm the cross-trial comparison; the populations are not comparable [rollback]
  2. (diff | hist) m b 17:15 Analytical method validation 5,342 ±0 CategoryBot (talk | contribs) bot: normalise citation format [rollback]
  3. (diff | hist) 17:03 Talk:Cold chain 1,296 +269 ColdChainCleo (talk | contribs) /* Domestic refrigerator claim: which studies? */ reply
  4. (diff | hist) m 15:22 Amino acid analysis 4,943 ±0 BiliaryBea (talk | contribs) state the column chemistry and the gradient the figure was obtained on [rollback]
  5. (diff | hist) 15:07 Glucagon-like peptide-1 12,294 ±0 LabelLibby (talk | contribs) clarify that the receptor is expressed outside the pancreas [rollback]
  6. (diff | hist) 14:22 Talk:Cold chain 1,085 +344 LabRangeLindy (talk | contribs) /* Domestic refrigerator claim: which studies? */ new section
  7. (diff | hist) 13:50 Talk:LEADER trial 748 +103 PreregPriya (talk | contribs) /* Enrichment and generalisation */ reply
  8. (diff | hist) 13:40 Talk:Test report forgery 885 +124 NPOV_Nadia (talk | contribs) /* Naming suppliers */ reply
  9. (diff | hist) 13:23 HOMA-IR 4,511 ±0 AxisLabelAgda (talk | contribs) convert the interval table to include both conventional and SI units [rollback]
  10. (diff | hist) 13:15 Talk:Beta cell function 611 +188 HOMA_Hettie (talk | contribs) /* Indices table is hard going */ reply
  11. (diff | hist) 10:20 Amylin receptor agonist 5,245 ±0 LeanMassLars (talk | contribs) fix the amino-acid substitution — position 8, not position 2 [rollback]
  12. (diff | hist) 10:15 Talk:LEADER trial 537 +130 LeaderLoic (talk | contribs) /* Enrichment and generalisation */ new section
  13. (diff | hist) 10:15 Talk:Test report forgery 674 +150 CoI_Corin (talk | contribs) /* Naming suppliers */ new section
  14. (diff | hist) 09:40 Talk:Beta cell function 400 +182 PlainNumbersPip (talk | contribs) /* Indices table is hard going */ new section
  15. (diff | hist) 08:55 International nonproprietary name 4,356 ±0 IcodecIndra (talk | contribs) correct the dose ladder — the maintenance dose is not the maximum dose [rollback]

18 May 2026

  1. (diff | hist) 20:03 Karl Fischer titration 9,318 ±0 Areapercent_Ayo (talk | contribs) expand §Relationship to other methods [rollback]
  2. (diff | hist) 19:12 Receptor bias 4,477 ±0 ColumnOvenCoy (talk | contribs) expand §The concept [rollback]
  3. (diff | hist) m 16:14 SinoPep 18,360 ±0 ScopeSeverin (talk | contribs) rm a duplicated category [rollback]
  4. (diff | hist) 13:50 Talk:Oral semaglutide 748 +82 DisclosureDido (talk | contribs) /* Powder sold as oral semaglutide */ reply
  5. (diff | hist) 13:10 Talk:Amino acid analysis 748 +136 AAA_Analyst (talk | contribs) /* Value for compounds without a standard */ reply
  6. (diff | hist) 10:15 Talk:Oral semaglutide 537 +133 VerifyVesna (talk | contribs) /* Powder sold as oral semaglutide */ new section
  7. (diff | hist) 09:35 Talk:Amino acid analysis 537 +182 RetatrutideRuben (talk | contribs) /* Value for compounds without a standard */ new section
  8. (diff | hist) m b 04:45 Batch number 4,573 ±0 StubSorterBot (talk | contribs) bot: update parent category chain [rollback]
  9. (diff | hist) 04:25 Vial 26,012 ±0 CouplingCillian (talk | contribs) split overlong sentence [rollback]
  10. (diff | hist) 03:23 Weight regain after discontinuation 4,670 ±0 ChainCustodyChad (talk | contribs) expand §Interpretation [rollback]
  11. (diff | hist) 02:35 High-performance liquid chromatography 7,231 ±0 Chromatokid (talk | contribs) alphabetise the see-also list [rollback]

17 May 2026

  1. (diff | hist) 23:29 Peptide content 8,404 ±0 ColumnOvenCoy (talk | contribs) add the cross-link to the compendial chapter [rollback]
  2. (diff | hist) m 22:35 Shenzhen Hybio Pharmaceutical 17,716 ±0 SurvodutideSaff (talk | contribs) de-orphan [rollback]
  3. (diff | hist) 21:16 Orforglipron 5,647 ±0 CustomsClarke (talk | contribs) give the strength per pen as well as per millilitre [rollback]
  4. (diff | hist) m 18:38 SURMOUNT trial programme 5,021 ±0 SecretagogueSol (talk | contribs) fix indentation in the source [rollback]
  5. (diff | hist) 15:48 Dual incretin agonist 5,851 ±0 RetatrutideRuben (talk | contribs) add the peptide length to the infobox [rollback]
  6. (diff | hist) 13:55 Talk:Fasting insulin 748 +104 SigFigSindri (talk | contribs) /* Assay-specific cut-offs */ reply
  7. (diff | hist) 13:50 Reference standard 5,217 ±0 OpenLabelOtto (talk | contribs) split §Principle from §Practical limitations [rollback]
  8. (diff | hist) m 11:12 PeptideMeter 4,925 ±0 UnderfillUna (talk | contribs) ce per PP:MOS [rollback]
  9. (diff | hist) 10:20 Talk:Fasting insulin 537 +114 LabRangeLindy (talk | contribs) /* Assay-specific cut-offs */ new section
  10. (diff | hist) m 08:15 Crude peptide 4,775 ±0 SupplyWatchSuri (talk | contribs) add the crimp-seal step to the fill-and-finish description [rollback]
  11. (diff | hist) 04:25 Contraindications of incretin therapy 4,993 ±0 ColdChainCleo (talk | contribs) add category for adverse effects [rollback]
  12. (diff | hist) 01:01 Arcuate nucleus 5,251 ±0 NPOV_Nadia (talk | contribs) give the fasting and postprandial concentrations with the assay named [rollback]

16 May 2026

  1. (diff | hist) m b 22:54 C-peptide 4,400 ±0 CiteBot (talk | contribs) bot: add stub category [rollback]
  2. (diff | hist) m b 19:36 Insulin syringe unit conversion 6,290 ±0 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  3. (diff | hist) 19:13 ISO 9001 4,278 ±0 ClinicCorrespondent (talk | contribs) ce [rollback]
  4. (diff | hist) 18:24 Qingdao Saber Technology Pharmaceutical 14,592 ±0 ChainCustodyChad (talk | contribs) state which lines are held in regional stock [rollback]
  5. (diff | hist) 14:35 Talk:Third-party testing 885 +207 NPOV_Nadia (talk | contribs) /* Should the service comparison table rank them? */ reply
  6. (diff | hist) 11:05 Talk:Third-party testing 674 +166 TallySheetTad (talk | contribs) /* Should the service comparison table rank them? */ new section
  7. (diff | hist) m 09:17 Reconstitution calculator 8,662 ±0 NotabilityNoa (talk | contribs) add category for interactive reference tools [rollback]
  8. (diff | hist) m 08:50 Loss on drying 4,874 ±0 MolarMassMaeve (talk | contribs) fix a dangling clause [rollback]
  9. (diff | hist) 04:41 TRIUMPH trial programme 4,703 ±0 SurrogateSunday (talk | contribs) add the comparator arm — an event rate alone says nothing [rollback]
  10. (diff | hist) 03:35 Zhuhai Kerui Biotechnology 14,711 ±0 Compounding_Cate (talk | contribs) state the city and province of the registered address [rollback]
  11. (diff | hist) 02:20 Bacteriostatic water 4,652 ±0 BacWaterBarnaby (talk | contribs) the rounding in the table lost a decimal place that matters at low doses [rollback]

15 May 2026

  1. (diff | hist) m 23:37 AmbioPharm 17,173 ±0 DrTitration (talk | contribs) rm the adjective — an organisation article describes, it does not praise [rollback]
  2. (diff | hist) 19:39 Hunan Aslsen Technology 15,492 ±0 LedgerLysander (talk | contribs) attribute the capability claim to the organisation's own material [rollback]
  3. (diff | hist) 17:54 Reverse-phase HPLC 5,499 ±0 ChromCleanupCass (talk | contribs) expand §Why it suits peptides [rollback]
  4. (diff | hist) 13:50 Talk:Resin cleavage 748 +70 Areapercent_Ayo (talk | contribs) /* Distinctive masses */ reply
  5. (diff | hist) 13:00 Talk:Repackaging 748 +121 SupplyWatchSuri (talk | contribs) /* Not irregular */ reply
  6. (diff | hist) 12:50 Talk:Limit of detection 748 +164 LOD_Lorcan (talk | contribs) /* Threshold table scope */ reply